Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Keratosis, Actinic
×
methyl 5-aminolevulinate
×
Clear all
Filters
3
NCT03511326
2021-02-18
SESAME 2
Galderma R&D
Phase 4
Completed
50 enrolled
9 charts
NCT01538901
2017-09-12
AKtransplant
Medical University of Vienna
Phase 4
Terminated
10 enrolled